Company Description
Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States.
It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.
The Critical Illness Recovery Hospital segment consists of hospitals that provide services for heart failure, infectious disease, respiratory failure and pulmonary disease, surgery requiring prolonged recovery, renal disease, neurological events, and trauma.
The Rehabilitation Hospital segment offers therapy and rehabilitation treatments, including rehabilitative services for brain and spinal cord injuries, strokes, amputations, neurological disorders, orthopedic conditions, pediatric congenital or acquired disabilities, and cancer.
The Outpatient Rehabilitation segment operates rehabilitation clinics that provide physical, occupational, and speech rehabilitation programs and services; and specialized programs, such as functional programs for work related injuries, hand therapy, post-concussion rehabilitation, pediatric and cancer rehabilitation, and athletic training services.
The Concentra segment operates and provides occupational health centers, telemedicine platforms, onsite clinics, and contract services at employer worksites that deliver occupational health services, consumer health, physical therapy, and preventive care.
Select Medical Holdings Corporation was founded in 1996 and is headquartered in Mechanicsburg, Pennsylvania.
| Country | United States |
| Founded | 1996 |
| IPO Date | Sep 25, 2009 |
| Industry | Medical Care Facilities |
| Sector | Healthcare |
| Employees | 54,600 |
| CEO | David S. Chernow |
Contact Details
Address: C/o Select Medical Corp, 4714 Gettysburg Rd Mechanicsburg, Pennsylvania 17055 United States | |
| Phone | 717-972-1100 |
| Website | selectmedical.com |
Stock Details
| Ticker Symbol | SEM |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001320414 |
| CUSIP Number | 81619Q105 |
| ISIN Number | US81619Q1058 |
| SIC Code | 8060 |
Key Executives
| Name | Position |
|---|---|
| Robert A. Ortenzio | Co-Founder and Executive Chairman |
| David S. Chernow | Chief Executive Officer |
| Rocco A. Ortenzio | Co-Founder and Vice Chairman |
| Michael F. Malatesta | Executive Vice President and Chief Financial Officer |
| Michael E. Tarvin | Senior Executive Vice President, General Counsel and Secretary |
| Martin F. Jackson | Senior Executive Vice President of Strategic Finance and Operations |
| John A. Saich | Co-President |
| Thomas P. Mullin | Co-President |
| Christopher S. Weigl | Senior Vice President, Controller and Chief Accounting Officer |
| Brian R. Rusignuolo | Executive Vice President and Chief Information Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 10, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Apr 8, 2024 | 144 | Filing |
| Mar 21, 2024 | DEFR14A | Filing |
| Mar 15, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Mar 15, 2024 | DEF 14A | Other definitive proxy statements |
| Mar 8, 2024 | 144 | Filing |
| Mar 4, 2024 | ARS | Filing |
| Feb 26, 2024 | PRE 14A | Other preliminary proxy statements |
| Feb 22, 2024 | 8-K | Current Report |
| Feb 22, 2024 | 10-K | Annual Report |